However, recent evidence from patients with NSCLC receiving programmed death 1 (PD-1) or PD-L1 inhibitor monotherapy suggests that the presence of brain metastases was not associated with poorer survival on the basis of multivariate analysis.9 Here, CD274 is linked to non-small cell lung carcinoma.